Theratechnologies Inc (THTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2019 | 11-2018 | 08-2018 | 05-2018 | 02-2018 | |
| Sales | 15,096 | 13,983 | 13,523 | 9,598 | 8,113 |
| Cost of Goods | 6,065 | 4,751 | 4,637 | 2,171 | 1,704 |
| Gross Profit | 9,031 | 9,232 | 8,886 | 7,427 | 6,409 |
| Operating Expenses | 9,556 | 9,912 | 9,438 | 9,304 | 9,124 |
| Operating Income | -460 | 71 | 85 | -1,706 | -2,011 |
| Interest Expense | 1,103 | 1,330 | 1,247 | 283 | 156 |
| Other Income | 335 | 276 | 175 | 77 | 80 |
| Pre-tax Income | -1,228 | -983 | -987 | -1,912 | -2,087 |
| Income Tax | N/A | N/A | -1,269 | N/A | N/A |
| Net Income Continuous | -1,228 | -983 | 282 | -1,912 | -2,087 |
| Net Income | $-1,228 | $-983 | $282 | $-1,912 | $-2,087 |
| EPS Basic Total Ops | -0.08 | 0.01 | -0.01 | -0.12 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | 0.01 | -0.10 | -0.11 |
| EPS Diluted Total Ops | -0.08 | 0.01 | -0.01 | -0.12 | -0.12 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | 0.01 | -0.10 | -0.11 |
| EBITDA(a) | $1,254 | $1,785 | $1,800 | $-1,286 | $-1,630 |